Sanofi has been preparing drug shortage contingency plans for over a year in the event that the U.K. fails to reach an agreement with the EU on Brexit, the Wall Street Journal reports, citing a person familiar with the matter. The move is the most recent sign that big European companies are concerned about the prospects of a hard Brexit, where the U.K. doesn’t reach a deal over its future relationship with the EU, the report notes
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.